Literature DB >> 25213784

Risk of statin-induced rhabdomyolysis in patients with hepatic impairment.

Nitin Kolhe1, Jeremy Lewis1, Thomas Alasdair McCulloch2.   

Abstract

We describe a case of a 54-year-old man with a 2-month history of biliary colic associated with a common bile duct stone. He underwent laparoscopic cholecystectomy and developed postoperative acute kidney injury stage 3. A renal biopsy was performed and demonstrated myoglobin in the renal tubules. Retrospective creatine kinase analysis was suggestive of rhabdomyolysis. It is thought this was precipitated by simvastatin accumulation in the context of a period of hepatic impairment and elevated liver enzymes. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25213784      PMCID: PMC4166132          DOI: 10.1136/bcr-2014-204013

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  7 in total

Review 1.  Rhabdomyolysis.

Authors:  Raymond Vanholder; Mehmet Sükrü Sever; Ekrem Erek; Norbert Lameire
Journal:  J Am Soc Nephrol       Date:  2000-08       Impact factor: 10.121

2.  Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial.

Authors:  G G Schwartz; A G Olsson; M D Ezekowitz; P Ganz; M F Oliver; D Waters; A Zeiher; B R Chaitman; S Leslie; T Stern
Journal:  JAMA       Date:  2001-04-04       Impact factor: 56.272

Review 3.  Statin-associated pleiotropy: possible beneficial effects beyond cholesterol reduction.

Authors:  Matthew K Ito; Robert L Talbert; Sotirios Tsimikas
Journal:  Pharmacotherapy       Date:  2006-07       Impact factor: 4.705

Review 4.  Potential metabolic consequences of statins in sepsis.

Authors:  David A Brealey; Mervyn Singer; Marius Terblanche
Journal:  Crit Care Med       Date:  2011-06       Impact factor: 7.598

5.  Benefit versus risk in statin treatment.

Authors:  John R Guyton
Journal:  Am J Cardiol       Date:  2006-01-30       Impact factor: 2.778

Review 6.  Clinical perspectives of statin-induced rhabdomyolysis.

Authors:  Kenneth A Antons; Craig D Williams; Steven K Baker; Paul S Phillips
Journal:  Am J Med       Date:  2006-05       Impact factor: 4.965

7.  Intensive versus moderate lipid lowering with statins after acute coronary syndromes.

Authors:  Christopher P Cannon; Eugene Braunwald; Carolyn H McCabe; Daniel J Rader; Jean L Rouleau; Rene Belder; Steven V Joyal; Karen A Hill; Marc A Pfeffer; Allan M Skene
Journal:  N Engl J Med       Date:  2004-03-08       Impact factor: 91.245

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.